A consortium including Ripple has launched a pilot to tokenize over $280 million worth of polished diamonds in Dubai, leveraging blockchain for ownership representation while key market mechanics remain under development.
BitMine Immersion Technologies (BMNR) shares continue their sharp decline, shedding nearly a third of their value in a month, as investors flee despite the chairman's defense of the company's massive unrealized losses on its Ethereum holdings. Technical indicators and a breakdown in chart structure suggest the sell-off has further to run.
The pharmaceutical giant AbbVie projects profits exceeding analyst expectations for 2026, buoyed by the stellar performance of its newer immunology drugs Skyrizi and Rinvoq, which are successfully offsetting the decline of its former top-seller Humira.
New benchmarking data reveals a staggering cost disparity in the invoicing process. Forward-thinking CFOs are redefining billing efficiency not as a back-office task, but as a critical lever for liquidity and customer relationships.
As consumer habits shift decisively toward mobile, Meta Platforms' AI-driven engagement growth presents a formidable challenge to streaming pioneer Netflix, reshaping the landscape of the digital attention economy.
A coalition of twelve leading European banks has established Qivalis, a joint venture aiming to issue a MiCA-compliant, euro-pegged stablecoin by late 2026, targeting faster, cheaper payments and digital asset settlement.
Amidst a backdrop of strong TSX earnings growth, savvy investors are scouring the market for hidden gems. We spotlight three Canadian companies whose current share prices appear significantly disconnected from their fundamental value, presenting potential opportunities for the discerning portfolio.
CME Group reported fourth-quarter revenue of $1.65 billion, aligning with analyst forecasts, as the world's largest derivatives exchange continues to benefit from sustained market volatility and hedging activity.
Amid a sharp downturn in crypto markets, Cathie Wood's ARK Invest has made significant purchases of crypto-linked equities, including a major stake in BitMine. The move comes as BitMine Chairman Tom Lee publicly defends the firm's long-term Ethereum strategy despite substantial paper losses.
OpenAI CEO Sam Altman has forcefully pushed back against reports of a growing rift with chip giant Nvidia, calling the speculation 'insanity' and publicly recommitting to a long-term partnership. His comments come amid market jitters over the future of a potential $100 billion investment and the shifting dynamics of the AI hardware race.
A persistent slump in shipping volumes is forcing a painful contraction across the U.S. supply chain, with major retailers, manufacturers, and logistics firms closing facilities and cutting thousands of jobs in early 2026.
Baron Discovery Fund's Q4 2025 letter reveals Primo Brands (PRMB) as a significant drag on performance, with shares down over 43% in the past year following disappointing results in its core water delivery segment.
In a major consolidation move within the semiconductor industry, Texas Instruments has agreed to acquire wireless connectivity specialist Silicon Labs for approximately $7.5 billion, aiming to expand its embedded systems portfolio and secure future growth.
GE HealthCare Technologies Inc. has issued an upbeat profit forecast for 2026, surpassing analyst expectations, as hospitals continue to invest heavily in diagnostic and imaging equipment amid steady procedural volumes.
Reynolds Consumer Products (NASDAQ: REYN) reported fourth-quarter sales that surpassed analyst expectations, though a weaker-than-anticipated revenue forecast for the coming quarter highlights ongoing challenges in volume growth for the household staples maker.
Long-term investors in Integra LifeSciences Holdings have seen their holdings decimated, with the stock's dramatic decline raising questions about the medical device maker's turnaround prospects and broader sector challenges.
The New York Times Company (NYSE: NYT) reported fourth-quarter revenue of $802.3 million, a 10.4% year-over-year increase that surpassed analyst expectations. While adjusted earnings per share met consensus, the results highlight both the strength of its digital transition and ongoing challenges in monetizing its growing subscriber base.
Ahold Delhaize's latest fair value estimate sees a marginal adjustment, yet the gap between bullish and bearish analyst targets remains wide. Behind the numbers, subtle changes in discount rates and growth forecasts signal an ongoing debate over the retail giant's resilience in a challenging market.
As GE HealthCare Technologies (GEHC) prepares to report quarterly earnings, investors are weighing anticipated revenue growth against recent stock weakness. The spotlight is also on the newly cleared Allia Moveo imaging system, seen as a key growth driver in a competitive medtech landscape.
As José Boisjoli prepares to step down, the powersports leader signals a strategic pivot toward emerging markets, driven by trade uncertainties and a saturated home market.
